CTI BioPharma Corp. Stock Forecast NASDAQ:CTIC

Price Target and Analyst Ratings

Most Recent Rating

On August 31, 2021 "JMP Securities" gave "$4.00" rating for CTIC. The price target was set to $2.96+3.9%.

Last 30 Days

Historical Ratings

Date	Rating	Action	Authority	Current Price	Target Price
2021-08-31	$4.00	Reiterated by	JMP Securities	$3.02	$2.96+3.9%
2021-08-09	$7.00	Initiated by	BTIG Research	$2.98	$2.80+10.7%
2021-07-30	$4.00	Reiterated by	JMP Securities	$2.37	$2.39
2021-06-01	Buy	Target Raised by	Lake Street Capital	$2.50	$13.00 → $15.00
2021-05-12	Buy	Initiated by	Stifel Nicolaus	$2.21	$5.50
2021-05-06	Buy	Initiated by	Stifel Nicolaus	$2.22	$5.50
2021-05-06	Buy	Initiated by	Stifel Nicolaus	$2.22
2021-01-04	Buy	Target Raised by	Lake Street Capital	$3.36	$8.00 → $13.00
2020-10-23	Buy	Initiated by	Brookline Capital Management	$3.50	$7.00
2020-09-30	Buy	Target Raised by	Needham & Company LLC	$2.15	$3.50 → $6.00
2020-07-05	Buy - Market Perform	Reiterated by	Lake Street Capital	$1.18	$4.00
2020-06-24	Outperform	Initiated by	JMP Securities	$1.21	$3.00

CTIC Stock Trend

The stock lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled.

Given the current short-term trend, the stock is expected to rise 34.67% during the next 3 months and, with a 90% probability hold a price between $3.79 and $4.37 at the end of this 3-month period.

WARNING: Trend forecast is still in the development phase and should be used with caution. Some cases might produce unexpected results such as negative prices at the end of the trend.

Data

Date	Bottom	Mid	Top
2021-09-20	$2.83	$3.04	$3.26
2021-09-21	$2.84	$3.06	$3.27
2021-09-22	$2.86	$3.07	$3.29
2021-09-23	$2.87	$3.08	$3.30
2021-09-24	$2.88	$3.10	$3.31
2021-09-27	$2.89	$3.11	$3.33
2021-09-28	$2.91	$3.12	$3.34
2021-09-29	$2.92	$3.14	$3.35
2021-09-30	$2.93	$3.15	$3.37
2021-10-01	$2.95	$3.16	$3.38
2021-10-04	$2.96	$3.18	$3.39
2021-10-05	$2.97	$3.19	$3.41
2021-10-06	$2.99	$3.20	$3.42
2021-10-07	$3.00	$3.22	$3.43
2021-10-08	$3.01	$3.23	$3.45
2021-10-11	$3.03	$3.24	$3.46
2021-10-12	$3.04	$3.26	$3.47
2021-10-13	$3.05	$3.27	$3.49
2021-10-14	$3.07	$3.28	$3.50
2021-10-15	$3.08	$3.30	$3.51
2021-10-18	$3.09	$3.31	$3.52
2021-10-19	$3.11	$3.32	$3.54
2021-10-20	$3.12	$3.34	$3.55
2021-10-21	$3.13	$3.35	$3.56
2021-10-22	$3.15	$3.36	$3.58
2021-10-25	$3.16	$3.38	$3.59
2021-10-26	$3.17	$3.39	$3.60
2021-10-27	$3.19	$3.40	$3.62
2021-10-28	$3.20	$3.42	$3.63
2021-10-29	$3.21	$3.43	$3.64

About CTI BioPharma Corp.

CTI BioPharma Corp., a biopharmaceutical company, engages in the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States and internationally. It primarily focuses on the commercialization of PIXUVRI, an aza-anthracenedione for the treatment of adult patients with multiply relapsed or refractory aggressive B-cell non-Hodgkin lymphoma in the European Union. The company is also devel... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!